| 17.65 -0.072 (-0.41%) | 12-12 12:25 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 26.83  |
1-year : | 30.88 |
| Resists | First : | 22.97 |
Second : | 26.44 |
| Pivot price | 20.1 |
|||
| Supports | First : | 17.35 |
Second : | 14.44 |
| MAs | MA(5) : | 17.99 |
MA(20) : | 20.74 |
| MA(100) : | 22.98 |
MA(250) : | 22.86 |
|
| MACD | MACD : | -1.6 |
Signal : | -1.3 |
| %K %D | K(14,3) : | 2.2  |
D(3) : | 1.5 |
| RSI | RSI(14): 23.6 |
|||
| 52-week | High : | 27.52 | Low : | 17.35 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SURI ] has closed above bottom band by 25.5%. Bollinger Bands are 220.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 24 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 17.7 - 17.82 | 17.82 - 17.92 |
| Low: | 17.03 - 17.2 | 17.2 - 17.33 |
| Close: | 17.41 - 17.64 | 17.64 - 17.82 |
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.
Wed, 11 Dec 2024
Where are the Opportunities in (SURI) - Stock Traders Daily
Wed, 27 Nov 2024
Simplify Provides Estimated Capital Gain Distribution Information for 2024 - Yahoo Finance
Wed, 27 Nov 2024
Simplify Provides Estimated Capital Gain Distribution Information for 2024 - Business Wire
Tue, 24 Sep 2024
Best-Performing ETFs of Last Week - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|